• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.54% Nasdaq Down 1.52%

    NovaBay Pharmaceuticals, Inc. (NBY)

    -NYSE MKT
    0.84 Up 0.01(1.20%) Apr 17, 4:00PM EDT
    Add to Portfolio
    Prev Close:0.83
    Open:0.80
    Bid:0.75 x 200
    Ask:0.89 x 200
    1y Target Est:1.45
    Beta:-0.19
    Earnings Date:Apr 29 - May 4 (Est.)
    Day's Range:0.79 - 0.87
    52wk Range:0.42 - 1.30
    Volume:157,554
    Avg Vol (3m):285,048
    Market Cap:51.33M
    P/E (ttm):N/A
    EPS (ttm):-0.31
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NBY

    Comparison

    Symbol% ChgMkt Cap
    NBYUp 1.20%51.33M
    ABTDown 0.58%69.79B
    PFEDown 0.43%214.76B
    SNNDown 0.76%15.25B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):48.13
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.21
    Quarterly EPS Est (Mar-15) :-0.06
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    NovaBay Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes topical non-antibiotic antimicrobial products for the eye care market. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback